...
首页> 外文期刊>Ecancermedicalscience >Research: Technique of sentinel lymph node biopsy and lymphatic mapping during laparoscopic colon resection for cancer
【24h】

Research: Technique of sentinel lymph node biopsy and lymphatic mapping during laparoscopic colon resection for cancer

机译:研究:腹腔镜结肠癌切除术中前哨淋巴结活检和淋巴标测技术

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The utility of lymph node mapping to improve staging in colon cancer is still under evaluation. Laparoscopic colectomy for colon cancer has been validated in multi-centric trials. This study assessed the feasibility and technical aspects of lymph node mapping in laparoscopic colectomy for colon cancer. Methods: A total of 42 patients with histologically proven colon cancer were studied from January 2006 to September 2007. Exclusion criteria were: advanced disease (clinical stage III), rectal cancer, previous colon resection and contraindication to laparoscopy. Lymph-nodal status was assessed preoperatively by computed tomography (CT) scan and intra-operatively with the aid of laparoscopic ultrasound. Before resection, 2¨C3 ml of Patent Blue V dye was injected sub-serosally around the tumour. Coloured lymph nodes were marked as sentinel (SN) with metal clips or suture and laparoscopic colectomy with lymphadenectomy completed as normal. In case of failure of the intra-operative procedure, an ex vivo SN biopsy was performed on the colectomy specimen after resection. Results: A total number of 904 lymph nodes were examined, with a median number of 22 lymph nodes harvested per patient. The SN detection rate was 100%, an ex vivo lymph node mapping was necessary in four patients. Eleven (26.2%) patients had lymph-nodal metastases and in five (45.5%) of these patients, SN was the only positive lymph node. There were two (18.2%) false-negative SN. In three cases (7.1%) with aberrant lymphatic drainage, lymphadenectomy was extended. The accuracy of SN mapping was 95.2% and negative predictive value was 93.9%. Conclusions: Laparoscopic lymphatic mapping and SN removal is feasible in laparoscopic colectomy for colon cancer. The ex vivo technique is useful as a salvage technique in case of failure of the intra-operative procedure. Prospective studies are justified to determine the real accuracy and false-negative rate of the technique
机译:背景:淋巴结定位图在结肠癌分期中的应用仍在评估中。腹腔镜结肠切除术用于结肠癌已在多中心试验中得到验证。这项研究评估了结肠癌腹腔镜结肠切除术中淋巴结定位的可行性和技术方面。方法:2006年1月至2007年9月,对42例经组织学证实为结肠癌的患者进行了研究。排除标准为:晚期疾病(临床III期),直肠癌,先前的结肠切除术和腹腔镜检查的禁忌症。术前通过计算机断层扫描(CT)扫描评估淋巴结状态,并在腹腔镜超声检查中进行术中评估。切除前,将2C3 ml的专利蓝V染料皮下注射至肿瘤周围。彩色淋巴结已用金属夹或缝合线标记为前哨(SN),腹腔镜结肠切除术及淋巴结清扫术均正常完成。如果术中操作失败,则在切除后对结肠切除标本进行离体SN活检。结果:共检查了904个淋巴结,每位患者平均采集了22个淋巴结。 SN检测率为100%,四名患者必须进行离体淋巴结定位。十一名(26.2%)患者发生淋巴结转移,其中五名(45.5%)患者中,SN是唯一的阳性淋巴结转移。有两个(18.2%)假阴性SN。 3例(7.1%)淋巴引流异常,扩大了淋巴结清扫术。 SN定位的准确性为95.2%,阴性预测值为93.9%。结论:腹腔镜结肠癌的腹腔镜结肠切除术是可行的。在术中手术失败的情况下,离体技术可用作抢救技术。有理由进行前瞻性研究以确定该技术的真实准确性和假阴性率

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号